Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Harland & Wolff enters five-year deal with global oil company

(Sharecast News) - Harland & Wolff Group announced a major new partnership on Wednesday, having signed a five-year master services agreement with an unnamed global oil services company. The AIM-traded firm said the agreement centred on the fabrication of large structures for subsea infrastructure projects essential to the oil and gas industry.

It said it had already received its first purchase order under the agreement.

The company would fabricate six specialised subsea structures, designed to withstand extreme pressures and vital to the operation of oil and gas platforms.

It said the contract was worth around £3m.

Construction would take place at the company's Arnish site over the next 18 months, with completion expected by the first half of 2025.

"This contract marks a significant step for the company and builds on the highly technical work the yard has already undertaken on suction anchors, piles and the work it is currently performing for the Sea Rose FPSO contract," said chief executive officer John Wood.

"These specialised subsea structures are a new product area for Harland & Wolff and we expect that successful delivery of this contract will open up significant opportunities for additional contracts in subsea infrastructure going forward."

At 1343 GMT, shares in Harland & Wolff Group Holdings were up 1.56% at 12.39p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Sirius Real Estate ups dividend as profits jump 32%
(Sharecast News) - Profits at business and industrial parks developer Sirius Real Estate surged by nearly a third in the year ended 31 March, helping the company to increase dividends for the tenth straight year.
GSK to appeal Delaware ruling on jury trials in Zantac cancer cases
(Sharecast News) - Pharma giant GSK said it would be appealing against a US court decision allowing jury trials in cases brought by cancer sufferers claiming its heartburn drug caused their condition.
AstraZeneca's lung cancer treatment recommended for approval in EU
(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommended for approval by European regulators.
China manufacturing PMI ticks up more than expected - Caixin
(Sharecast News) - Activity in China's manufacturing sector grew in May at the fastest rate in two years, according to data released on Monday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.